SKYRIZI sol inj 150 mg/ml ser pré
7680669440022
CH-66944
L04AC18
07.15.0.
Reimbursement limitations:
SKYRIZI.01
Formes sévères de psoriasis en plaque (seulement dosage à 150 mg)
La prescription médicale ne …
1 / 3
google
Details
- Product number
- 6694402
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- risankizumabum 150 mg, natrii acetas trihydricus corresp. natrium 0.209 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Skyrizi 150 mg, lnjektionslösung in einer Fertigspritze
Fertigspritze
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.209 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 3146.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2021
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 66944
- Drug name
- Skyrizi, lnjektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AC18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SKYRIZI sol inj 150 mg/ml ser pré
- Description (DE)
- SKYRIZI Inj Lös 150 mg/ml Fertspr
- Market launch
- 07/07/2021
- Narcotic (BTM)
- No